Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor-Positive Breast Cancer and Oligometastatic Disease in the Brain

Clin Breast Cancer. 2016 Jun;16(3):e61-3. doi: 10.1016/j.clbc.2016.02.013. Epub 2016 Feb 12.
No abstract available

Keywords: Brain metastases in breast cancer; Hormone receptor–positive breast cancer; Oligometastatic brain metastases; Treatment options for brain metastases in breast cancer; Young patients with breast cancer.

Publication types

  • Case Reports

MeSH terms

  • Anastrozole
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / therapy*
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy
  • Carcinoma, Ductal, Breast / secondary*
  • Carcinoma, Ductal, Breast / therapy
  • Carcinoma, Intraductal, Noninfiltrating / secondary
  • Carcinoma, Intraductal, Noninfiltrating / therapy
  • Carmustine / administration & dosage
  • Chemoradiotherapy / methods
  • Craniotomy
  • Cyclophosphamide / administration & dosage
  • Decanoic Acids / administration & dosage
  • Disease-Free Survival
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Leuprolide / administration & dosage
  • Nitriles / administration & dosage
  • Paclitaxel / administration & dosage
  • Polyesters / administration & dosage
  • Radiosurgery
  • Receptors, Estrogen / biosynthesis
  • Triazoles / administration & dosage
  • Young Adult

Substances

  • Decanoic Acids
  • Nitriles
  • Polyesters
  • Receptors, Estrogen
  • Triazoles
  • carmustine, poliferprosan 20 drug combination
  • Anastrozole
  • Doxorubicin
  • Cyclophosphamide
  • Leuprolide
  • Paclitaxel
  • Carmustine